Mustafa Durgun

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 13, 2026
CA IX Inhibition by a Sulfonamide Compound: A Therapeutic Approach Against Breast Cancer.

Sükrü Akmese, Ebru Temiz, Elif Gürel

|Feb 07, 2024
Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.

Ismail Koyuncu, Ebru Temiz, Eray Metin Güler

|Dec 27, 2023
Design and Synthesis of Pyrazole Carboxamide Derivatives as Selective Cholinesterase and Carbonic Anhydrase Inhibitors: Molecular Docking and Biological Evaluation.

Mustafa Durgun, Suleyman Akocak, Nebih Lolak

|Jul 02, 2021
Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.

Ebru Temiz, Ismail Koyuncu, Mustafa Durgun

|May 05, 2021
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.

Cüneyt Türkeş, Suleyman Akocak, Mesut Işık

|Jul 22, 2020
Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies.

Parham Taslimi, Mesut Işık, Fikret Türkan

Pageof 2

Frequent Collaborators

4 joint publications

Ismail Koyuncu

4 joint publications

Claudiu T Supuran

3 joint publications

Ataman Gonel

3 joint publications

Ebru Temiz